Presentation

Universidad de Granada | Dep. Arquitectura y Tecnología de Computadores, UGR | IWBBIO 2016 |

Slideshow Photo by WOWSlider.com v4.7

Special issues (tentative)

A list of papers with very high quality will be selected to be extended and submitted in different special issues. We have currently contacted these journals (tentative list):

Biomedical Engineering Online (BMC).

Genomics and Computational Biology.

Current Topics in Medicinal Chemistry.

Journal of Biomedical Engineering and Biosciences.

Biomedical Engineering Online (BMC): Instructions for authors with template - BMC- Appendix B.

Journal of Biomedical Engineering and Biosciences

IWBBIO also collaborates with the following thematic issue:

Towards the integration of Quantitative and Systems Pharmacology into drug discovery: a systems level understanding of therapeutic and toxic effects of drugs
Dr. Violeta Perez Nueno Executive Guest Editor Current Pharmaceutical Design Journal (IF: 3.452). Over the past three decades, the predominant paradigm in drug discovery was designing selective ligands for a specific target to avoid unwanted side effects. However, in the last 5 years, the aim has shifted to take into account the biological network in which they interact. Quantitative and Systems Pharmacology (QSP) is a new paradigm that aims to understand how drugs modulate cellular networks in space and time, in order to predict drug targets and their role in human pathophysiology. This issue will go trough the current computational and experimental QSP approaches such as polypharmacology techniques combined with systems biology information and consider the use of new tools and ideas in a wider 'systems-level' context in order to design new drugs with improved efficacy and fewer unwanted off-target effects. Subtopics of the Thematic Issue: Polypharmacology / Target fishing Network pharmacology Systems pharmacology Translational research Personalized medicine Gene-disease associations and drug toxicities Side effects prediction Computational tools for QSP
How the thematic issue will contribute to the field Nowadays, large-scale associations between drug molecules, their protein targets, and their side-effects represents the holy grail of the pharmaceutical industry. Thus, the issue deals with a hot topic in the current pharmaceutical design field: http://www.roche.com/media/store/roche_stories/roche-stories-2015-12-14.htm This thematic issue will be of broad interest for the research community.
Instructions Research Articles are not acceptable in a thematic issue. They must be review/mini-review articles. They can be reviews or can include accounts of the author's research work combined with a review of the recent literature so that the readers will gain access to a broad perspective of the field. Authors must submit copyright form for their articles. Email addresses of all co-authors of each article as well as photographs of the main authors are required. For "Instructions to Authors", as to how the MS should be prepared, please visit the website linked here. DEADLINE FOR PAPER SUBMISSIONS: 29th April, 2016.

Towards the integration of Quantitative and Systems Pharmacology into drug discovery: a systems level understanding of therapeutic and toxic effects of drugs

Dr. Violeta Perez Nueno
Executive Guest Editor
Current Pharmaceutical Design Journal (IF: 3.452).

Over the past three decades, the predominant paradigm in drug discovery was designing selective ligands for a specific target to avoid unwanted side effects. However, in the last 5 years, the aim has shifted to take into account the biological network in which they interact. Quantitative and Systems Pharmacology (QSP) is a new paradigm that aims to understand how drugs modulate cellular networks in space and time, in order to predict drug targets and their role in human pathophysiology.

This issue will go trough the current computational and experimental QSP approaches such as polypharmacology techniques combined with systems biology information and consider the use of new tools and ideas in a wider 'systems-level' context in order to design new drugs with improved efficacy and fewer unwanted off-target effects.

Subtopics of the Thematic Issue:

Polypharmacology / Target fishing
Network pharmacology
Systems pharmacology
Translational research
Personalized medicine
Gene-disease associations and drug toxicities
Side effects prediction
Computational tools for QSP

How the thematic issue will contribute to the field

Nowadays, large-scale associations between drug molecules, their protein targets, and their side-effects represents the holy grail of the pharmaceutical industry. Thus, the issue deals with a hot topic in the current pharmaceutical design field:

http://www.roche.com/media/store/roche_stories/roche-stories-2015-12-14.htm

This thematic issue will be of broad interest for the research community.

Instructions

Research Articles are not acceptable in a thematic issue. They must be review/mini-review articles. They can be reviews or can include accounts of the author's research work combined with a review of the recent literature so that the readers will gain access to a broad perspective of the field.

Authors must submit copyright form for their articles.

Email addresses of all co-authors of each article as well as photographs of the main authors are required.

For "Instructions to Authors", as to how the MS should be prepared, please visit the website linked here.

DEADLINE FOR PAPER SUBMISSIONS: 29th April, 2016.

Journal: Molecules Tentative topic: Advances in Drug Discovery
Dr. Horacio Perez-Sanchez PhD Bioinformatics and High Performance Computing Research Group Universidad Católica San Antonio de Murcia (UCAM) Spain Website: http://bio-hpc.eu; Email: hperez@ucam.edu Executive Guest Editor News: Newly Released Impact Factor for Molecules (2014): 2.416.

Tweets from @iwbbio15